{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:46:36Z","timestamp":1791351996107,"version":"4.3.1"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T00:00:00Z","timestamp":1237420800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0004917","type":"journal-article","created":{"date-parts":[[2009,3,18]],"date-time":"2009-03-18T22:46:49Z","timestamp":1237416409000},"page":"e4917","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Dendritic Cell-Mediated-Immunization with Xenogenic PrP and Adenoviral Vectors Breaks Tolerance and Prolongs Mice Survival against Experimental Scrapie"],"prefix":"10.1371","volume":"4","author":[{"given":"Martine Bruley","family":"Rosset","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Sacquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Lecollinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Chaigneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheline","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Crespeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Eloit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,3,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1212\/WNL.42.1.149","article-title":"Nearly ubiquitous tissue distribution of the scrapie agent precursor protein.","volume":"42","author":"PE Bendheim","year":"1992","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0092-8674(00)81163-0","article-title":"Prion protein biology.","volume":"93","author":"SB Prusiner","year":"1998","journal-title":"Cell"},{"key":"ref3","first-page":"1781","article-title":"Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol.","volume":"298","author":"J Ma","year":"2002","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuron.2007.01.005","article-title":"Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice.","volume":"53","author":"GR Mallucci","year":"2007","journal-title":"Neuron"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"39671","DOI":"10.1074\/jbc.M402270200","article-title":"PrPSc binding antibodies are potent inhibitors of prion replication in cell.","volume":"279","author":"V Beringue","year":"2004","journal-title":"J Biol Chem"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1073\/pnas.151242598","article-title":"Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.","volume":"98","author":"M Enari","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"18524","DOI":"10.1074\/jbc.M210723200","article-title":"Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells.","volume":"78","author":"S Gilch","year":"2003","journal-title":"J Biol Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1111\/j.1460-9568.2006.04805.x","article-title":"Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.","volume":"23","author":"J Pankiewicz","year":"2006","journal-title":"Eur J Neurosci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1126\/science.1063093","article-title":"Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies.","volume":"294","author":"FL Heppner","year":"2001","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35089090","article-title":"Antibodies inhibit prion propagation and clear cell cultures of prion infectivity.","volume":"412","author":"DR Peretz","year":"2001","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1073\/pnas.0404772101","article-title":"Humoral immune response to native eukariotic prion protein correlates with anti-prion protection.","volume":"101","author":"M Polymenidou","year":"2004","journal-title":"PNAS"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nature01457","article-title":"Monoclonal antibodies inhibit prion replication and delay the development of prion disease.","volume":"422","author":"AR White","year":"2003","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"11247","DOI":"10.1074\/jbc.M407006200","article-title":"Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells.","volume":"280","author":"C Feraudet","year":"2005","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/15264","article-title":"Scrapie replication in lymphoid tissues depends on protein prion-expressing follicular dendritic cells.","volume":"5","author":"KL Brown","year":"1999","journal-title":"Nat Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1099\/0022-1317-83-1-267","article-title":"Migrating intestinal dendritic cells transport PrP<sup>Sc<\/sup> from the gut.","volume":"83","author":"FP Huang","year":"2002","journal-title":"J Gen Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1172\/JCI200113155","article-title":"Infected splenic dendritic cells are sufficient for prion neuroinvasion in RAG-1<sup>0\/0<\/sup> mice.","volume":"108","author":"P Aucouturier","year":"2001","journal-title":"J Clin Invest"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.4049\/jimmunol.170.12.6040","article-title":"Immunologically induced, complement-dependent upregulation of the prion protein in the mouse spleen: Follicular dendritic cells versus capsule and trabeculae.","volume":"170","author":"M L\u00f6tscher","year":"2003","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.4049\/jimmunol.177.9.6137","article-title":"Prion protein expression by mouse dendritic cells is restricted to nonplasmacytoid subsets and correlates with the maturation state.","volume":"177","author":"G Martinez del Hoyo","year":"2006","journal-title":"J Immunol"},{"key":"ref19","first-page":"175","article-title":"Disease-associated prion protein oligomers inhibit the 26S proteasome.","volume":"26","author":"M Kristiansen","year":"2007","journal-title":"MolCell"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4049\/jimmunol.111.5.1407","article-title":"Failure to demonstrate a humoral immune response to scrapie infection in mice.","volume":"111","author":"DD Porter","year":"1973","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.4049\/jimmunol.172.9.5168","article-title":"Breaking immune tolerance to the prion protein (PrP) with PrP peptides plus oligo-CpG in mice.","volume":"172","author":"M Bruley Rosset","year":"2004","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1189\/jlb.1203656","article-title":"Identification of two immunogenic domains of the prion protein-PrP-which activate class-II restricted T cells and elicit antibody responses against the native molecule.","volume":"76","author":"S Gr\u00e9goire","year":"2004","journal-title":"J Leukoc Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.4049\/jimmunol.175.10.6443","article-title":"The murine B-cell repertoire is severely selected against endogenous cellular prion protein.","volume":"175","author":"S Gr\u00e9goire","year":"2005","journal-title":"J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4049\/jimmunol.181.1.768","article-title":"Contribution of antibody and T cell-specific responses to the progression of 139A-scrapie in C57BL\/6 mice.","volume":"181","author":"A Sacquin","year":"2008","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1128\/JVI.79.7.4033-4042.2005","article-title":"Circumventing tolerance to the prion protein (PrP): vaccination with PrP displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP.","volume":"79","author":"D Nikles","year":"2005","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/j.1742-4658.2007.05721.x","article-title":"Vaccination with prion peptide-dispaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells.","volume":"274","author":"A Handisurya","year":"2007","journal-title":"FEBS J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.vaccine.2006.09.078","article-title":"Immunization with recombinant bovine but not mouse protein delays the onset of disease in mice inoculated with a mouse-adapted prion.","volume":"25","author":"D Ishibashi","year":"2007","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1158\/0008-5472.CAN-05-4018","article-title":"Vaccination with human HER-2\/neu (435\u2013443) CTL peptide induces effective antitumor immunity against HER-2\/neu-expressing tumor cells in vivo.","volume":"66","author":"AD Gritzapis","year":"2006","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.188.2.277","article-title":"gp100\/pmel 17 is a murine tumor rejection antigen: Induction of self-reactive, tumoricidal T cells using high-affinity, altered peptide ligand.","volume":"188","author":"WW Overwijk","year":"1998","journal-title":"J Exp Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/blood-2003-12-4319","article-title":"Multistep process through which adenoviral vector vaccine overcomes anergy to tumor-associated antigens.","volume":"104","author":"Y Tang","year":"2008","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/intimm\/14.1.31","article-title":"Prime-boost immunization generates a high frequency, high-avidity CD8+ cytotoxic T lymphocyte population.","volume":"14","author":"MJ Estcourt","year":"2002","journal-title":"Int Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ijc.21188","article-title":"Efficient induction of T-cell responses to carcinoembryonic antigen by a heterologous prime-boost regimen using DNA and adenovirus vectors carrying a codon usage optimized cDNA.","volume":"117","author":"C Mennuni","year":"2005","journal-title":"Int J Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0167-5699(00)01612-1","article-title":"The prime-boost strategy: exciting prospects for improved vacination.","volume":"21","author":"IA Ramshaw","year":"2000","journal-title":"Immunol Today"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1006\/bbrc.2001.5208","article-title":"Nervous and non nervous cell transduction by recombinant adenoviruses that inducibly express the human PrP.","volume":"285","author":"S Arrabal","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.4049\/jimmunol.168.5.2393","article-title":"Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity.","volume":"168","author":"N Shibagaki","year":"2002","journal-title":"J Immuno"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.20071859","article-title":"Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection.","volume":"205","author":"M Holdener","year":"2008","journal-title":"J Exp Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1586\/14760584.6.3.347","article-title":"T-cell immunity generated by recombinant adenovirus vaccines.","volume":"63","author":"TC Yang","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1089\/vim.2006.19.210","article-title":"Induction of specific immune response in vivo after vaccination with dendritic cells transduced with adenoviral vectors encoding hepatitis C virus NS3.","volume":"19","author":"M Xiang","year":"2006","journal-title":"Viral Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors.","volume":"10","author":"N Tatsis","year":"2004","journal-title":"Mol Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.4049\/jimmunol.176.12.7254","article-title":"Functional implication of cellular prion rotein in antigen-driven interactions between T cells and dendritic cells.","volume":"176","author":"C Ballerini","year":"2006","journal-title":"J Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.4049\/jimmunol.175.9.6032","article-title":"Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors.","volume":"175","author":"SE Hensley","year":"2005","journal-title":"J Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.vetmic.2007.03.032","article-title":"Immunisation strategies against prion disease: prime-boost immunisation with a PrP DNA vaccine containing foreign helper T-cell epitopes does not prevent mouse scrapie.","volume":"123","author":"C Nitschke","year":"2007","journal-title":"Vet Microbiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1016\/j.vaccine.2004.11.067","article-title":"Decrease in pathology and progression of scrapie after immunization with synthetic prion protein peptides in hamsters.","volume":"23","author":"G Magri","year":"2005","journal-title":"Vaccine"},{"key":"ref44","first-page":"286","article-title":"Complete Freund&apos;s adjuvant immunization prolongs survival in experimental prion disease in mice.","volume":"71","author":"Y Tal","year":"2002","journal-title":"J NeuroSc"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.neuroscience.2005.02.031","article-title":"Mucosal vaccination delays or prevents prion infection via an oral route.","volume":"133","author":"F Goni","year":"2005","journal-title":"NeuroScience"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.vaccine.2005.12.051","article-title":"Intranasal immunization of Balb\/c mice against prion protein attenuates orally acquired transmissible spongiform encephalopathy.","volume":"24","author":"S Bade","year":"2006","journal-title":"Vaccine"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(03)00907-8","article-title":"Immunization with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent.","volume":"350","author":"A Schwarz","year":"2003","journal-title":"Neuroscience Letters"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1016\/j.vaccine.2005.12.054","article-title":"Enhanced mucosal immunogenicity of prion protein following fusion with B subunit of Escherichia coli heat-labile enterotoxin.","volume":"24","author":"H Yamanaka","year":"2006","journal-title":"Vaccine"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"9970","DOI":"10.1128\/JVI.01210-06","article-title":"DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge.","volume":"80","author":"N Fernandez-Borges","year":"2006","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.4049\/jimmunol.179.5.2797","article-title":"Polylactide-coglycolide microspheres co-encapsulating recombinant tandem prion protein with CpG-oligonucleotide break self-tolerance to prion protein in wild-type mice and induce CD4 and CD8 T cell responses.","volume":"179","author":"G Kaiser-Schulz","year":"2007","journal-title":"J Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1128\/JVI.77.6.3799-3808.2003","article-title":"T cells infiltrate the brain in murine and human transmissible spongiform encephalopathies.","volume":"77","author":"H Lewicki","year":"2003","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.immuni.2008.08.004","article-title":"Cancer Immunotherapy by dendritic cells.","volume":"29","author":"CJ Melief","year":"2008","journal-title":"Immunity"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1371\/journal.pone.0001419","article-title":"Proeminent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD.","volume":"3","author":"V Beringue","year":"2008","journal-title":"J PloS ONE"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1099\/vir.0.82816-0","article-title":"Experimental scrapie in \u2018plt\u2019 mice: an assessement of the role of dendritic-cell migration in the pathogenesis of prion diseases.","volume":"88","author":"E Levavasseur","year":"2007","journal-title":"J Gen Virol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0004917","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T14:08:16Z","timestamp":1684937296000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0004917"}},"subtitle":[],"editor":[{"given":"Neil","family":"Mabbott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,3,19]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,3,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0004917","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,19]]}}}